Reimbursement of COVID-19 Tests

Since the COVID-19 pandemic began, various screening tests for the virus have become available. Our insured members are reimbursed according to the following conditions:

Test name SARS-COV-2 detection  Conditions Reimbursement

RT-PCR test 

and

Rapid Antigen Test

 

 

Updated by the OFSP on 02.11.2020 and available in France since 31.10.2020

Mucous membrane swab.

Detection and diagnosis of the virus in case of symptoms or suspicion.

 

For medical reasons 

RT-PCR test: carried out in a test centre or drive-in recognised by the health authorities or on its mandate.

Rapid Antigen Test: carried out in pharmacies, nursing offices, doctors' surgeries

And

In strict compliance with the requirements pertaining to suspicion or to tracing.

Reimbursed according to the General Rule.

(without a medical prescription)

For medical reasons 

RT-PCR test: carried out by a healthcare professional at or a doctor’s surgery.

Reimbursed according to the General Rule.

(upon presentation of a medical prescription)

For travel

Not reimbursed
Serological test 

Blood sample.

Identification of the presence of IgM and IgG antibodies specific to SARS-COV-2.

Determines an individual’s immune status at the time of blood sample, i.e. whether he or she has developed antibodies to the virus.

Serological analyses must be carried out exclusively by analysis laboratories that are authorised to perform them, in accordance with the laws governing epidemics and the associated implementing orders.

These tests are not relevant for the diagnosis of virus infection.

Not reimbursed

Serological tests

available over the counter in pharmacies or online, without medical prescription

Self-test performed by dripping droplets of blood onto testing strips. These tests are not medically recognised: the results are unreliable as false positives and negatives occur frequently. Not reimbursed